GlobalData provides unique and market-leading data and insights into the other diseases market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Polycystic Kidney Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • January 2021
GlobalData's clinical trial report, “Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Polycystic Kidney Diseas Clinical trials scenario. This report provides top line data...

Fabry Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • January 2021
GlobalData's clinical trial report, “Fabry Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Fabry Disease Clinical trials scenario. This report provides top line data relating to...

Down Syndrome Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • November 2020
GlobalData's clinical trial report, “Down Syndrome Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Down Syndrome Clinical trials scenario. This report provides top line data relating...

Fragile X Syndrome Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • November 2020
GlobalData's clinical trial report, “Fragile X Syndrome Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Fragile X Syndrome Clinical trials scenario. This report provides top line...

Prader-Willi Syndrome (PWS) Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • November 2020
GlobalData's clinical trial report, “Prader-Willi Syndrome (PWS) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Prader-Willi Syndrome (PWS) Clinical trials scenario. This report provides top line...

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • November 2020
GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )...

Duchenne Muscular Dystrophy Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • October 2020
GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Critical Limb Ischemia Clinical trials scenario. This report provides top line...

Microalbuminuria Disease – Global Clinical Trials Review, H2, 2020

  • $2,500
  • October 2020
GlobalData's clinical trial report, “Microalbuminuria Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Microalbuminuria Clinical trials scenario. This report provides top line data relating to the...

Fabry Disease – Global Clinical Trials Review, H2 2020

  • $2,500
  • October 2020
GlobalData's clinical trial report, “Fabry Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Fabry Disease Clinical trials scenario. This report provides top line data relating to...

Non-Proliferative Diabetic Retinopathy (NPDR) Disease – Global Clinical Trials Review, H2 2020

  • $2,500
  • October 2020
GlobalData's clinical trial report, “Non-Proliferative Diabetic Retinopathy (NPDR) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Non-Proliferative Diabetic Retinopathy (NPDR) Clinical trials scenario. This report provides...